News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
73–108
Matches
238
Sources here
15
Companies here
6
Search results Stored financial headlines

Active search

238 matching headlines

Ticker or company: URUMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

ETFs Investing in CarGurus, Inc. Class A Stocks

This article lists various Exchange Traded Funds (ETFs) that hold CarGurus, Inc. Class A stocks. It provides a detailed table including each fund's market value, weight of CarGurus stock, issuer, management style, focus, expense ratio, assets under management (AUM), price, change, relative volume, and …

CARG main company
Sharemaestro market context Trend signal active 52 weeks +9.5% · Next-week setup positive 58.7% CARG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Arcturus Therapeutics Holdings Inc expected to post a loss of 100 cents a share - Earnings Preview

Arcturus Therapeutics Holdings Inc (ARCT) is anticipated to report a loss of 100 cents per share in its upcoming earnings. This forecast is part of an earnings preview, suggesting investors and analysts are closely watching the company's financial performance. The full article provides more …

ARCT main company
Sharemaestro market context Price above Trend Line 52 weeks -55.5% ARCT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

CarGurus (CARG) insider files to sell 6,205 Class A shares after prior sales

CarGurus Class A stockholder Javier Zamora has filed a notice to sell 6,205 Class A shares through Fidelity Brokerage Services LLC, with an aggregate market value of $226,792.75, planned for August 3, 2026. This filing also details previous sales by Zamora in June and …

CARG main company
Sharemaestro market context Trend signal active 52 weeks +9.5% · Next-week setup positive 58.7% CARG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

CarGurus, Inc. (NASDAQ:CARG) Receives Consensus Recommendation of "Moderate Buy" from Analysts

CarGurus, Inc. (NASDAQ:CARG) has received a consensus "Moderate Buy" rating from fourteen analysts, with an average 12-month price target of $38.55. The company recently surpassed quarterly expectations, reporting $0.58 EPS against a $0.56 consensus and $243.56 million in revenue, an 8.2% year-over-year increase. Insiders …

CARG main company
Sharemaestro market context Trend signal active 52 weeks +9.5% · Next-week setup positive 58.7% CARG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Glenmede Trust Co. NA Lowers Position in CarGurus, Inc. $CARG

Glenmede Trust Co. NA reduced its stake in CarGurus, Inc. (NASDAQ:CARG) by 13.0% in the first quarter, now holding 406,707 shares worth $13.85 million. Other institutional investors also adjusted their positions, with several increasing their holdings. Analysts have a "Moderate Buy" consensus rating for …

CARG main company
Sharemaestro market context Trend signal active 52 weeks +9.5% · Next-week setup positive 58.7% CARG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

102,401 Shares in CarGurus, Inc. $CARG Purchased by Healthcare of Ontario Pension Plan Trust Fund

Healthcare of Ontario Pension Plan Trust Fund has acquired 102,401 shares of CarGurus, Inc. (NASDAQ:CARG) valued at approximately $3.49 million, contributing to institutional investors owning 86.9% of the company. CarGurus surpassed Q1 expectations with adjusted EPS of $0.58 and revenue of $243.56 million, an …

CARG main company
Sharemaestro market context Trend signal active 52 weeks +9.5% · Next-week setup positive 58.7% CARG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

CarGurus, Inc. $CARG Shares Sold by The Manufacturers Life Insurance Company

The Manufacturers Life Insurance Company reduced its stake in CarGurus (NASDAQ:CARG) by 8.1% in Q1 2026, selling 148,823 shares but still holding 1.70 million shares valued at $57.8 million. CarGurus reported strong Q1 earnings of $0.58 per share, beating estimates, with revenue up 8.2% …

CARG main company
Sharemaestro market context Trend signal active 52 weeks +9.5% · Next-week setup positive 58.7% CARG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Lazard Asset Management LLC Purchases 287,067 Shares of CarGurus, Inc. $CARG

Lazard Asset Management LLC significantly increased its holdings in CarGurus, Inc. by 180.8% in the first quarter, acquiring an additional 287,067 shares to bring its total to 445,868 shares valued at $15.2 million. This move comes as CarGurus reported strong first-quarter earnings, beating revenue …

CARG main company
Sharemaestro market context Trend signal active 52 weeks +9.5% · Next-week setup positive 58.7% CARG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Arcturus Therapeutics Holdings Inc (ARCT) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Arcturus Therapeutics Holdings Inc (ARCT), detailing its volatility, financial risk, and investment risk. It highlights the company's current risk assessment score, its beta value compared to the S&P 500 index, and various financial metrics such as maximum …

ARCT main company
Sharemaestro market context Price above Trend Line 52 weeks -55.5% ARCT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Arcturus Therapeutics to Report Second Quarter Financial Results and Provide Corporate Update on Aug 6, 2026

Arcturus Therapeutics Holdings Inc. (Nasdaq: ARCT) announced it will release its second-quarter financial results for 2026 on Thursday, August 6th, after market close. The company will also host a conference call and webcast at 4:30 p.m. Eastern Time on the same day to provide …

ARCT main company
Sharemaestro market context Price above Trend Line 52 weeks -55.5% ARCT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Arcturus Therapeutics Q2 Results: Financials and update due Aug 6

Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) is scheduled to release its Q2 2026 financial results after market close on August 6, 2026, followed by a conference call at 4:30 p.m. ET for a corporate update. While no specific financial figures are in the pre-announcement, …

ARCT main company
Sharemaestro market context Price above Trend Line 52 weeks -55.5% ARCT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

CarGurus, Inc. Class A Revenue Breakdown – SWB:0C6

CarGurus, Inc. Class A (SWB:0C6) generated 772.22 million EUR last year, with its Automotive Platform segment contributing the entirety of this revenue. The majority of this revenue, specifically 704.38 million EUR, came from the United States market. This data highlights the company's concentration in …

CARG main company
Sharemaestro market context Trend signal active 52 weeks +9.5% · Next-week setup positive 58.7% CARG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

CarGurus Consumers Drop Lawsuit Over ShinyHunters Data Breach

A proposed class action lawsuit against CarGurus Inc. has been voluntarily dismissed by consumers following a data breach attributed to ShinyHunters. The lawsuit alleged that CarGurus failed to implement adequate data-security measures and provide timely notification after the February attack, which reportedly exposed 12.5 …

CARG main company
Sharemaestro market context Trend signal active 52 weeks +9.5% · Next-week setup positive 58.7% CARG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Arcturus Therapeutics Market Sentiment

This article provides an overview of market sentiment for Arcturus Therapeutics (ARCT), including analyst consensus, short interest, options flow, and insider activity. Analysts have a "Buy" consensus with an average price target significantly higher than the current price, despite rising short interest. The report …

ARCT main company
Sharemaestro market context Price above Trend Line 52 weeks -55.5% ARCT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Arcturus Therapeutics Holdings Inc

This article provides details on Arcturus Therapeutics Holdings Inc (ARCT), including its current stock price and market capitalization. It highlights that revenue breakdown data by business segment and region has not yet been disclosed by the company. The page also offers general information about …

ARCT main company
Sharemaestro market context Price above Trend Line 52 weeks -55.5% ARCT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Arcturus Therapeutics Holdings Inc (ARCT) Cash Flow

This article provides a detailed cash flow statement for Arcturus Therapeutics Holdings Inc (ARCT), covering quarterly and annual data from FY2012Q3 to FY2026Q1. It breaks down operating, investing, and financing cash flows, along with specific components like capital expenditures and changes in working capital. …

ARCT main company
Sharemaestro market context Price above Trend Line 52 weeks -55.5% ARCT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Weekly Recap: CARG Q2 results and Barclays raises target to $40

CarGurus, Inc. (NASDAQ:CARG) is scheduled to report its Q2 2026 earnings on August 6, 2026, after market close. Barclays has raised its price target for CARG to $40 from $35, maintaining an Overweight rating on the stock. This update provides key financial dates and …

CARG main company
Sharemaestro market context Trend signal active 52 weeks +9.5% · Next-week setup positive 58.7% CARG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Arcturus Therapeutics Holdings Inc (ARCT) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Arcturus Therapeutics Holdings Inc (ARCT) focusing on its dividend and stock split history. It states that the company has not distributed dividends over the past five years. Key financial data like market capitalization and recent stock performance are …

ARCT main company
Sharemaestro market context Price above Trend Line 52 weeks -55.5% ARCT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Arcturus Therapeutics Holdings Inc (ARCT) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Arcturus Therapeutics Holdings Inc (ARCT), listing its major shareholders and institutional holdings. Key shareholders include Federated Hermes Global Investment Management Corp., ARK Investment Management LLC, and BlackRock Institutional Trust Company, N.A., alongside data on institutional shareholding trends …

ARCT main company
Sharemaestro market context Price above Trend Line 52 weeks -55.5% ARCT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Arcturus Therapeutics Holdings Inc. (ARCT) Stock Price | Live Quotes & Charts | NASDAQ

This page provides live quotes and charts for Arcturus Therapeutics Holdings Inc. (ARCT) on NASDAQ, showing its current stock price and performance. It indicates that Arcturus Therapeutics' stock is down by 4.84% at $5.79, with delayed prices. The page also presents a lack of …

ARCT main company
Sharemaestro market context Price above Trend Line 52 weeks -55.5% ARCT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

CarGurus, Inc. (CARG) Stock Forecasts

CarGurus, Inc. (CARG) is an online automotive marketplace connecting car buyers and sellers. Argus has lowered its target price for CARG to $38.00, with the current price at $33.37. The report provides a summary of the company and encourages users to upgrade for full …

CARG main company
Sharemaestro market context Trend signal active 52 weeks +9.5% · Next-week setup positive 58.7% CARG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

CARG|CarGurus Inc|Price:33.370|Chg%:+0.410

CarGurus Inc (CARG) is an online automotive platform with strong fundamentals and high growth potential, currently trading at $33.37. The company's valuation is considered fairly valued within the Software & IT Services industry, with analysts generally rating it as a "Buy" and a target …

CARG main company
Sharemaestro market context Trend signal active 52 weeks +9.5% · Next-week setup positive 58.7% CARG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

ARCT|Arcturus Therapeutics Holdings Inc|Price:5.530|Chg%:-0.260

This article provides a financial summary of Arcturus Therapeutics Holdings Inc (ARCT), detailing its latest earnings report from May 7, 2026, and presenting historical quarterly and annual financial metrics. It covers key indicators such as EPS, revenue, net profit, various margins, and balance sheet …

ARCT main company
Sharemaestro market context Price above Trend Line 52 weeks -55.5% ARCT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Arcturus Therapeutics Holdings Inc. Revenue Breakdown – NASDAQ:ARCT

This article provides a revenue breakdown for Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT). Last year, the company generated $82.03 million USD, primarily from its Messenger Ribonucleic Acid Medicines segment, and the largest contribution came from the United States. This marks a decrease from $152.31 …

ARCT main company
Sharemaestro market context Price above Trend Line 52 weeks -55.5% ARCT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context